Emergent BioSolutions (EBS) Receivables (2010 - 2026)
Emergent BioSolutions (EBS) posted Receivables of $211.2 million for Q2 2026, up 50.96% on a QoQ basis from $139.9 million in Q1 2026, and up 105.65% year-over-year from $102.7 million in Q2 2025.
Powered by 
Analysis
Emergent BioSolutions (EBS) Receivables (2010 - 2026) Analysis & Trends
Emergent BioSolutions has reported Receivables for 17 years, with the latest figure at $211.2 million in Q2 2026.
- On a quarterly basis, Receivables rose 105.65% year-over-year to $211.2 million in Q2 2026; TTM through Jun 2026 was $211.2 million, a 105.65% increase from a year earlier, with the FY2025 full-year figure at $102.4 million, down 41.18% from the prior year.
- Receivables was $211.2 million for Q2 2026 at Emergent BioSolutions, up from $139.9 million in the prior quarter.
- The five-year high for Receivables was $341.9 million in Q2 2023, with the low at $102.4 million in Q4 2025.
- Average Receivables over 5 years is $214.0 million, with a median of $223.2 million recorded in 2022.
- The sharpest annual moves came in 2025 and 2026: Receivables tumbled 63.16% in 2025, then surged 105.65% in 2026.
- Over 5 years, Receivables stood at $216.4 million in 2022, then increased by 12.01% to $242.4 million in 2023, then fell by 28.18% to $174.1 million in 2024, then slumped by 41.18% to $102.4 million in 2025, then jumped by 106.25% to $211.2 million in 2026.
- The last three Receivables figures came in at $211.2 million (Q2 2026), $139.9 million (Q1 2026), and $102.4 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.47 Bn | 628.71 Bn | 17.26 Bn | 19.05 Bn |
| 2 | AbbVie | 467.46 Bn | 460.93 Bn | 12.70 Bn | 13.82 Bn |
| 3 | Merck | 369.31 Bn | 362.22 Bn | 12.21 Bn | 12.56 Bn |
| 4 | Novartis Ag | 269.03 Bn | 261.74 Bn | 11.24 Bn | 9.64 Bn |
| 5 | Pfizer | 158.11 Bn | 146.71 Bn | 10.94 Bn | 12.49 Bn |
| 6 | Bristol Myers Squibb | 127.96 Bn | 116.89 Bn | 9.25 Bn | 10.66 Bn |
| 7 | Sanofi | 51.83 Bn | 44.86 Bn | 10.79 Bn | 10.13 Bn |
| 8 | BeOne Medicines | 41.33 Bn | 36.23 Bn | 1.53 Bn | 1.06 Bn |
| 9 | Revolution Medicines | 41.30 Bn | 41.30 Bn | - | - |
| 10 | Emergent BioSolutions | 335.50 Mn | 194.60 Mn | 137.20 Mn | 211.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 211.20 Mn |
| Mar 31, 2026 | 139.90 Mn |
| Dec 31, 2025 | 102.40 Mn |
| Sep 30, 2025 | 168.80 Mn |
| Jun 30, 2025 | 102.70 Mn |
| Mar 31, 2025 | 234.60 Mn |
| Dec 31, 2024 | 174.10 Mn |
| Sep 30, 2024 | 140.50 Mn |
| Jun 30, 2024 | 278.80 Mn |
| Mar 31, 2024 | 275.10 Mn |
| Dec 31, 2023 | 242.40 Mn |
| Sep 30, 2023 | 277.50 Mn |
| Jun 30, 2023 | 341.90 Mn |
| Mar 31, 2023 | 205.70 Mn |
| Dec 31, 2022 | 216.40 Mn |
| Sep 30, 2022 | 261.50 Mn |
| Jun 30, 2022 | 230.10 Mn |
| Mar 31, 2022 | 248.40 Mn |
| Dec 31, 2021 | 330.50 Mn |
| Sep 30, 2021 | 312.20 Mn |
API Access
Emergent BioSolutions Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=EBS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "EBS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=EBS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();